Co-registration of cardiac MRI and rest gated SPECT in the assessment of myocardial perfusion, function and viability

Journal of Cardiovascular Magnetic Resonance

Volumn 8, Issue 2, 2006, Pages 389-397

  Misko, Jolanta ^a   Dziuk, Mirosław ^b   Skrobowska, Ewa ^b   Szalus, Norbert ^b   Pietrzykowski, Jacek ^b   Warczynska, Agnieszka ^b  

^a Central Railway Hospital Warsaw   (Poland)

^b MILITARY INSTITUTE OF MEDICINE   (Poland)

Author keywords

Cardiac MRI; Image Fusion; Myocardial Function; Myocardial Perfusion; Myocardial Viability; SPECT

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; TECHNETIUM 99M;

ADULT; AGED; ARTICLE; CLINICAL PRACTICE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIAGNOSTIC IMAGING; FEMALE; HEART FUNCTION; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE PERFUSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REGISTRATION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

AGED; AGED, 80 AND OVER; CORONARY DISEASE; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMAGING, THREE-DIMENSIONAL; MAGNETIC RESONANCE IMAGING, CINE; MALE; MIDDLE AGED; RADIOPHARMACEUTICALS; STATISTICS, NONPARAMETRIC; TECHNETIUM TC 99M SESTAMIBI; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 33644818479     PISSN: 10976647     EISSN: 1532429X     Source Type: Journal    
DOI: 10.1080/10976640500452083     Document Type: Article

References (39)

1. Heusch G. Hibernating Myocardium. Physiological Reviews 1998;78:1055-85.
2. Allman KC, Shaw LJ, Hachamovitch R, Udelson JE. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. J Am Coll Cardiol 2002;39:1151-8.
3. Pasquet A, Robert A, D'Hondt AM, Dion R, Melin JA, Vanoverschelde JL. Prognostic value of myocardial ischemia and viability in patients with chronic left ventricular ischemic dysfunction. Circulation 1999;100:141-8.
4. Sharir T, Germano G, Kang X, Lewin HC, Miranda R, Cohen I, Agafitei RD, Friedman JD, Berman DS. Prediction of Myocardial Infarction Versus Cardiac Death by Gated Myocardial Perfusion SPECT:Risk Stratification by the Amount of Stress-Induced Ischemia and the Poststress Ejection Fraction. J of Nucl Med 2001;42:831-7.
5. Wilson JM. Reversible congestive heart failure caused by myocardial hibernation. Tex Heart Inst J 1999;26:19-27.
6. Rahimtoola SH. A perspective on the three large multicenter randomized clinical trials of coronary bypass surgery for chronic stable angina. Circulation 1985;72:V-123-35.
7. Brown TA. Hibernating myocardium. Am J Crit Care 2001;10:84-91.
8. Soman P, Udelson AJ. Prognostic and therapeutic implications of myocardial viability in patients with heart failure. Curr Cardiol Rep 2004;6:211-6.
9. Elsasser A, Schlepper M, Klovekorn WP, Cai WJ, Zimmermann R, Muller KD, Strasser R, Kostin S, Gagel C, Munkel B, Schaper W, Schaper J. Hibernating myocardium: an incomplete adaptation to ischemia. Circulation 1997;96:2920-31.
10. Gunning MG, Kaprielian RR, Pepper J, Pennell DJ, Sheppard MN, Severs NJ, Fox KM, Underwood R. The histology of viable and hibernating myocardium in relation to imaging characteristics. J Am Coll Cardiol 2002;39:428-35.
11. Gerber BL, Garot J, Bluemke DA, Wu KC, Lima JA. Accuracy of contrast - enhanced magnetic resonance imaging in predicting improvement of regional myocardial function in patients after acute myocardial infarction. Circulation 2002;106:1083-9.
12. Soto JR, Beller GA. Clinical benefit of noninvasive viability studies of patients with severe ischemic left ventricular dysfunction. Clin Cardiol 2001;24:428-34.
13. Watzinger N, Saeed M, Wendland MF, Akbari H, Lund G, Higgins CB. Myocardial viability: magnetic resonance assessment of functional reserve and tissue characterization. J Cardiovasc Magn Reson 2001;3:195-208.
14. Kim RJ, Shah DJ, Judd RM. How we perform delayed enhancement imaging. J Cardiovasc Magn Reson 2003;5:505-14.
15. Kuhl HP, Beek AM, van der Weerdt AP, Hofman MBM, Visser CA, Lammertsma AA, Heussen N, Visser FC, van Rossum AC. Myocardial viability in chronic ischemic heart disease-comparison of contrast - enhanced magnetic resonance imaging with 18F-fluorodeoxyglucose positron emission tomography. J Am Coll Cardiol 2003;41:1341-8.
16. Klein C, Nekolla SG, Bengel FM, Momose M, Sammer A, Haas F, Schnackenburg B, Delius W, Mudra H, Wolfram D, Schwaiger M. Assessment of myocardial viability with contrast - enhanced magnetic resonance imaging - comparison with positron emission tomography. Circulation 2002;105:162-7.
17. Kim RJ, Fieno DS, Parrish TB, Harris K, Chen EL, Simonetti O, Bundy J, Finn JP, Klocke FJ, Judd RM. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 1999;100:1992-2002.
18. Kim RJ, Wu E, Rafael A, Chen EL, Parker MA, Simonetti O, Klocke FJ, Bonow RO, Judd RM. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 2000;343:1445-53.
19. Schvartzman PR, Srichai MB, Grimm RA, Obuchowski NA, Hammer DF, McCarthy PM, Kasper JM, White RD. Nonstress delayed-enhancement magnetic resonance imaging of the myocardium predicts improvement of function after revascularization for chronic ischemic heart disease with left ventricular dysfunction. Am Heart J 2003;146:535-40.
20. Choi KM, Kim RJ, Gubernikoff G, Vargas JD, Parker M, Judd RM. Transmural extent of acute myocardial infarction predicts long-term improvement in contractile function. Circulation 2001;104:1101-7.
21. Gerber BL, Garot J, Bluemke DA, Wu KC, Lima JAC. Accuracy of contrast-enhanced magnetic resonance imaging in predicting improvement of regional myocardial function in patients after acute myocardial infarction. Circulation 2002;106:1083-9.
22. Shan K, Constantine G, Sivananthan M, Flamm SD. Role of cardiac magnetic resonance imaging in the assessment of myocardial viability. Circulation 2004;109:1328-34.
23. Hillenbrand HB, Kim RJ, Parker MA, Fieno DS, Judd RM. Early assessment of myocardial salvage by contrast - enhanced magnetic resonance imaging. Circulation 2000;102:1678-83.
24. Wu E, Judd RM, Vargas JD, Klocke FJ, Bonow RO, Kim RJ. Visualization of presence, location, and transmural extent of healed Q-wave and non-Q-wave myocardial infarction. Lancet 2001;357:21-8.
25. Kim RJ, Judd RM. Fundamental concepts in myocardial viability assessment revisited: when knowing how much is "alive" is not enough. Heart 2004;90:137-40.
26. Kim RJ, Hillenbrand HB, Judd RM. Evaluation of myocardial viability by MRI. Herz 2000;25:417-30.
27. Wagner A, Mahrholdt H, Holly TA, Elliott MD, Regenfus M, Parker M, Klocke FJ, Bonow RO, Kim RJ. Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study. Lancet 2003;361:374-9.
28. Gunning MG, Anagnostopoulos C, Knight CJ, Pepper J, Burman ED, Davies G, Fox KM, Pennell DJ, Underwood SR. Comparison of thallium-201, technetium-99m-tetrofosmin and dobutamine magnetic resonance imaging for identifying hibernating myocardium. Circulation 1998;98:1869-74.
29. Gibbons RJ, Miller TD, Christian TF. Infarct size measured by SPECT imaging with 99mTc-Sestamibi - a measure of the efficacy of therapy in acute myocardial infarction. Circulation 2000;101:101-8.
30. Cuocolo A, Acampa W, Nicolai E, Pace L, Petretta M, Salvatore M. Quantitative thallium-201 and technetium 99m sestamibi tomography at rest in detection myocardial viability in patients with chronic ischemic left ventricular dysfunction. J Nucl Cardiol 2000;7:8-15.
31. Murashita T, Makino Y, Kamikubo Y, Yasuda K, Mabuchi M, Tamaki N. J Quantitative gated myocardial perfusion single photon emission computed tomography improves the prediction of regional functional recovery in akinetic areas after coronary bypass surgery: useful tool for evaluation of myocardial viability. Thorac Cardiovasc Surg 2003;126:1328-34.
32. Ross J. Myocardial perfusion-contraction matching. Implications for coronary heart disease and hibernation Circulation 1983:1076-83.
33. Schmidt M, Voth E, Schneider CA, Theissen P, Wagner R, Baer FM, Schicha H. F-18-FDG uptake is a reliable predictory of functional recovery of akinetic but viable infarct regions as defined by magnetic resonance imaging before and after revascularization. Magn Reson Imaging 2004;22:229-36.
34. Rehwald WG, Fieno DS, Chen EL, Kim RJ, Judd RM. Myocardial magnetic resonance imaging contrast agent concentration after reversible and irreversible ischemic injury. Circulation 2002;105:224-9.
35. Slomka PJ. Software approach to merging molecular with anatomic information. J Nucl Med 2004;45 Suppl1:36S-45S.
36. Aladl UE, Hurwitz GA, Dey D, Levin D, Drangova M, Slomka PJ. Automated image registration of gated cardiac single-photon emission computed tomography and magnetic resonance imaging. J Magn Reson Imaging 2004;19(3):283-90.
37. Miller TD, Christian TE, Hopfensprirger MR, Hodge DO, Gersh BJ, Gibbons RJ. Infarct size after acute myocardial infarction measured by quantitative tomographic 99mTc sestamibi imaging predicts subsequent mortality. Circulation 1995;92:334-41.
38. Hurrell DG, Milavetz J, Hodge DO, Gibbons RJ. Infarct size determination by technetium 99m sestamibi single-photon emission computed tomography predicts survival in patients with chronic coronary artery disease. Am Heart J 2000;140:61-6.
39. Fieno DS, Kim RJ, Chen EL, Lomansney JW., Klocke FJ, Judd RM. Contrast - enhanced magnetic resonance imaging of myocardium at risk: Distinction between reversible and irreversible injury throughout infarct healing. J Am Coll Cardiol 2000;36:1985-91.